Citations

Showing 10 of 108083 citations.

Submucous Ulcer of the Bladder in the Male
Bumpus, Hermon C.

Mayo Clinic

Journal of Urology | July 20, 2017 | Volume: 5 | Issue: 3 | Pages: 249-254

10.1016/s0022-5347(17)74101-8 Get It

The Follow-Up Record in Cases of Tumor of the Bladder
Crenshaw, John L.

Mayo Clinic

Journal of Urology | July 20, 2017 | Volume: 5 | Issue: 3 | Pages: 211-214

10.1016/s0022-5347(17)74098-0 Get It

Urinary Extracellular Vesicles of Podocyte Origin and Renal Injury in Preeclampsia
Gilani, Sarwat, Anderson, Ulrik Dolberg, Jayachandran, Muthuvel , Weissgerber, Tracey L. , Zand, Ladan , Milić, Nataša , Vallapureddy, Rangit, Nääv, Åsa , Erlandsson, Lena , Grande, Joseph P. , Nath, Karl A. , Hansson, Stefan R. , White, Wendy M, Garovic, Vesna D. , White, Wendy , Suarez, Maria Lourdes Gonzalez , Lieske, John C. , Weissgerber, Tracey L , Milic, N

Mayo Clinic

Journal of the American Society of Nephrology | July 20, 2017 | Volume: 28 | Issue: 11 | Pages: 3363-3372

10.1681/asn.2016111202 | PMID 28729288 Get It

Renal histologic expression of the podocyte-specific protein, nephrin, but not podocin, is reduced in preeclamptic compared with normotensive pregnancies. We hypothesized that renal expression of podocyte-specific proteins would be reflected in urinary extracellular vesicles (EVs) of podocyte origin and accompanied by increased urinary soluble nephrin levels (nephrinuria) in preeclampsia. We further postulated that podocyte injury and attendant formation of EVs are related mechanistically to cellfree fetal hemoglobin (HbF) in maternal plasma. Our study population included preeclamptic ( n =49) and normotensive ( n =42) pregnant women recruited at delivery. Plasma measurements included HbF concentrations and concentrations of the endogenous chelators haptoglobin, hemopexin, and α 1- microglobulin. We assessed concentrations of urinary EVs containing immunologically detectable podocyte-specific proteins by digital flow cytometry and measured nephrinuria by ELISA. The mechanistic role of HbF in podocyte injury was studied in pregnant rabbits. Compared with urine from women with normotensive pregnancies, urine from women with preeclamptic pregnancies contained a high ratio of podocin-positive to nephrin-positive urinary EVs (podocin + EVs-to-nephrin + EVs ratio) and increased nephrinuria, both of which correlated with proteinuria. Plasma levels of hemopexin, which were decreased in women with preeclampsia, negatively correlated with proteinuria, urinary podocin + EVs-to-nephrin + EVs ratio, and nephrinuria. Administration of HbF to pregnant rabbits increased the number of urinary EVs of podocyte origin. These findings provide evidence that urinary EVs are reflective of preeclampsia-related altered podocyte protein expression. Furthermore, renal injury in preeclampsia associated with an elevated urinary podocin + EVs-to-nephrin + EVs ratio and may be mediated by prolonged exposure to cellfree HbF.
Pediatric Functional Magnetic Resonance Imaging: Clinical Applications
Welker, Kirk M. , Ho, Mai‐Lan , Ho, Mai-Lan

Mayo Clinic

Journal of Pediatric Neurology | July 20, 2017 | Volume: 16 | Issue: 02 | Pages: 078-093

10.1055/s-0037-1604216 Get It

AbstractTask-based functional magnetic resonance imaging (fMRI) is an imaging technique based on blood oxygenation level-dependent imaging. Maps of brain activation are generated during the performance of designated tasks involving eloquent functions, such as motor, sensory, visual, auditory, and/or language. Optimal performance of fMRI in children requires consideration of multiple psychological and physiological parameters. Also, a solid technical understanding is needed for appropriate study design, implementation, processing, and interpretation. In this article, the authors review the key principles of fMRI technique, study design, data processing, and interpretation. The important clinical applications in the pediatric population will be highlighted, accompanied by example cases from their institution.
New-Onset Heart Failure and Mortality in Hospital Survivors of Sepsis-Related Left Ventricular Dysfunction
Vallabhajosyula, Saraschandra , Geske, Jeffrey B. , Sakhuja, Ankit , Singhal, Akhil, Poterucha, Joseph T., Murphy, Joseph G. , Jentzer, Jacob C. , Kumar, Mukesh , Kashani, Kianoush , Gajic, Ognjen , Kashyap, Rahul , Vallabhajosyula, Saraschandra , Geske, Jeffrey B

Mayo Clinic

Shock | July 20, 2017 | Volume: 49 | Issue: 2 | Pages: 144-149

10.1097/shk.0000000000000952 | PMID 28727607 Get It

Abstract Background: The association between new-onset left ventricular (LV) dysfunction during sepsis with long-term heart failure outcomes is lesser understood. Methods: Retrospective cohort study of all adult patients with severe sepsis and septic shock between 2007 and 2014 who underwent echocardiography within 72 h of admission to the intensive care unit. Patients with prior heart failure, LV dysfunction, and structural heart disease were excluded. LV systolic dysfunction was defined as LV ejection fraction <50% and LV diastolic dysfunction as ≥grade II. Primary composite outcome included new hospitalization for acute decompensated heart failure and all-cause mortality at 2-year follow-up. Secondary outcomes included persistent LV dysfunction, and hospital mortality and length of stay. Results: During this 8-year period, 434 patients with 206 (48%) patients having LV dysfunction were included. The two groups had similar baseline characteristics, but those with LV dysfunction had worse function as demonstrated by worse LV ejection fraction, cardiac index, and LV diastolic dysfunction. In the 331 hospital survivors, new-onset acute decompensated heart failure hospitalization did not differ between the two cohorts (15% vs. 11%). The primary composite outcome was comparable at 2-year follow-up between the groups with and without LV dysfunction (P = 0.24). Persistent LV dysfunction was noted in 28% hospital survivors on follow-up echocardiography. Other secondary outcomes were similar between the two groups. Conclusions: In patients with severe sepsis and septic shock, the presence of new-onset LV dysfunction did not increase the risk of long-term adverse heart failure outcomes.
Intestinal Transit Time and Cortisol-Mediated Stress in Zebrafish
Brady, Clayton , Denora, Maxwell, Shannon, Ian, Clark, Karl J. , Rich, Adam , Clark, Karl J , Brady, Clayton T

Mayo Clinic

Zebrafish | July 20, 2017 | Volume: 14 | Issue: 5 | Pages: 404-410

10.1089/zeb.2017.1440 | PMID 28727940 Get It

48 Utilisation of cardiac implantable electronic device therapy in patientswith attr-wild type amyloidosis with concurrent cardiac involvement
Chahal, C. Anwar A. , Padmanabhan, Deepak , Tandon, Nidhi , Grogan, Martha , Brady, Peter A. , Lin, Grace , Somers, Virend K. , Dispenzieri, Angela , Chahal, Choudhary Anwar A

Mayo Clinic

Heart | July 20, 2017 | Volume: 103 | Issue: Suppl 5 | Pages: A38.1-A38

10.1136/heartjnl-2017-311726.47 Get It

Introduction The role of cardiac implantable electronic device (CIED) therapy in patients with ATTR-wt (senile) amyloid is not very well defined. It is unknown whether there is mortality benefit or harm with the implantation of CIEDs. Methods We performed a retrospective analysis of a prospectively collected registry of patients with biopsy proven ATTR-wt amyloid with cardiac involvement. These patients were followed up at Mayo Clinic, Rochester, Minnesota between Jan 1, 1985 to Sep 30, 2015. The follow-up of these patients was done via personal communication (written or verbal) and entered into the database. During analysis these patients were subdivided on the basis of the presence or absence of a CIED, cardiac involvement or not, and all-cause mortality analysed. The implantation of a CIED was analysed as a time-dependent covariate in the survival of these patients and Kaplan-Meier (K-M) survival plots created. Comparison between groups with CIED and those without CIED was made. In addition, CIEDs were subdivided into permanent pacemakers (PPM), defibrillators (ICDs) and cardiac resynchronization devices (CRT-P/D). Mortality among the patients with each device subtype was estimated and compared to overall mortality. Results 409 patients with ATTR-wt and cardiac involvement were reviewed with CIEDs implanted in 101 (25%) patients. The median follow-up (25th, 75th centile) was 2.4 (1.1, 4.3) years. Utilisation of ICDs in this population was higher than the general community in Olmsted county. There was no association in the overall survival or evidence of harm with CIED utilisation in patients with ATTR amyloidosis and cardiac involvement. Conclusions CIEDs utilisation remains high in ATTR-wt with cardiac involvement. Due diligence is needed in selecting the optimal patient for benefit prior to the implantation of CIEDs in this cohort. Further research is required to pool multi-centre amyloid registry data and determine if there is mortality benefit.
TRAIL deletion prevents liver inflammation but not adipose tissue inflammation during murine diet‐induced obesity
Weng, Peggy, Salim, Warda, Bronk, Steven F., Griffith, Thomas S. , Ibrahim, Samar H. , Hirsova, Petra , Gores, Gregory J. , Ibrahim, Samar H

Mayo Clinic

Hepatology Communications | July 20, 2017 | Volume: 1 | Issue: 7 | Pages: 648-662

10.1002/hep4.1069 | PMID 29124251 Get It

Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) and its cognate receptor(s) are up‐regulated in human and murine nonalcoholic steatohepatitis (NASH); however, the consequence of this enhanced expression on NASH pathogenesis remains unclear. TRAIL may either accentuate liver injury by promoting hepatic steatosis and inflammation or it may mitigate the disease process by improving systemic insulin resistance and averting hepatic fibrosis. Herein, we investigated the role of TRAIL in an obesity‐induced murine model of NASH. C57BL/6 wild‐type mice and Trail –/– mice were placed on a 20‐week standard chow or a high‐fat, high‐fructose, and high‐cholesterol (FFC) diet, which induces obesity, insulin resistance, and NASH. Metabolic phenotype, liver injury, inflammation and fibrosis, and adipose tissue homeostasis were examined. FFC diet‐fed Trail –/– mice displayed no difference in weight gain and metabolic profile when compared to wild‐type mice on the same diet. All FFC‐fed mice developed significant hepatic steatosis, which was attenuated in Trail –/– mice. TRAIL deficiency also significantly decreased FFC diet‐induced liver injury as manifested by reduced serum alanine aminotransferase values, hepatic terminal deoxynucleotidyl transferase‐mediated deoxyuridine triphosphate nick‐end labeling‐positive cells, and macrophage‐associated inflammation. FFC diet‐associated hepatic stellate cell activation and hepatic collagen deposition were also abrogated in Trail –/– mice. In contrast to the liver, TRAIL deletion did not improve FFC diet‐induced adipose tissue injury and inflammation and actually aggravated insulin resistance. Conclusion: NASH pathogenesis may be dissociated from other features of the metabolic syndrome, and liver‐targeted inhibition of TRAIL signaling may be salutary. (Hepatology Communications 2017;1:648–662)
Severe Aortic Valve Stenosis Due to Alkaptonuric Ochronosis
Ahmed, Magdy M. El‐Sayed , Ott, David A., Aftab, Muhammad , El-Sayed Ahmed, Magdy M, Hussain, Omar Khadeer

Mayo Clinic

Seminars in Cardiothoracic and Vascular Anesthesia | July 20, 2017 | Volume: 21 | Issue: 4 | Pages: 364-366

10.1177/1089253217720284 | PMID 28709382 Get It

Alkaptonuric ochronosis is a rare cause of aortic valve stenosis. We report the case of a 61-year-old female patient with alkaptonuria who presented to our institute with the clinical picture of severe aortic valve stenosis, which was confirmed by transthoracic echocardiography. On aortotomy, she was noted to have an impressive black discoloration of ascending aorta and the aortic root complex involving the aortic valve leaflets. She underwent an uneventful aortic valve replacement. She was discharged home 10 days postoperatively.
Ultrasound guided percutaneous common carotid artery access in piglets for intracoronary stem cell infusion
Taggart, Nathaniel W. , Edgerton, Sarah, Peral, Susana Cantero, Holst, Kimberly , Cetta, Frank , Anderson, Jason H. , Edgerton, Sarah L, Cantero Peral, Susana, Holst, Kimberly A, Taggart, Nathaniel W

Mayo Clinic

Laboratory Animals | July 20, 2017 | Volume: 52 | Issue: 1 | Pages: 88-92

10.1177/0023677217719923 | PMID 28708034 Get It

In pigs, the deep location of the common carotid artery and overlying sternomastoideus muscle in the neck has led to the recommendation for a surgical cutdown for common carotid access, as opposed to minimally invasive techniques for vascular access. We sought to determine if direct percutaneous common carotid artery access in piglets is attainable. Seventeen piglets were anesthetized and intubated. Under two-dimensional and color flow Doppler ultrasound guidance, a 21 gauge needle was utilized to access the right common carotid artery. Following arterial puncture, the Seldinger technique was applied to place a 4 or 5 French introducer. Upon completion of cardiac catheterization with intracoronary stem cell infusion the introducer was removed and manual pressure was applied to prevent hematoma development. Successful access with an introducer was achieved in all 17 piglets. The average weight was 8.5 ± 1.7 kg. One piglet developed a hematoma with hemorrhaging from the catheterization site and was euthanized. This piglet was given bivalirudin for the procedure. After this incident, subsequent piglets were not given anticoagulation and no other complications occurred. Ultrasound guided percutaneous common carotid artery access in piglets is attainable in a safe, reliable, and reproducible manner when performed by microvascular experts.